Healthcare -
Biotechnology - NASDAQ - US
$ 0.549
1.9 %
$ 2.6 M
Market Cap
-0.11
P/E
PCSA - SHORT-TERM DEBT
Short-term Debt PCSA - Processa Pharmaceuticals, Inc.
83.6 K
LAST VALUE
-23.29%
2 YEAR CAGR
-18.31%
5 YEAR CAGR
-18.30%
10 YEAR CAGR